DXCM (DexCom) Cyclically Adjusted FCF per Share: $0.94 (As of Mar. 2026)


DXCM DexCom Inc DXCM
90 GF Score
Price $68.86
GF Value $103.81
Valuation Significantly Undervalued
! 3 Warning Signs
View Full Analysis

What is DexCom Cyclically Adjusted FCF per Share?

DexCom DXCM +2.24% 90 Cyclically Adjusted FCF per Share is $0.94 as of Mar. 2026. GuruFocus rates DXCM with a GF Score™ of 90/100 and a GF Value™ of $103.81 (Significantly Undervalued). The stock has 3 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

DexCom's adjusted free cash flow per share for the three months ended in Mar. 2026 was $1.141. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is $0.94 for the trailing ten years ended in Mar. 2026.

During the past 12 months, DexCom's average Cyclically Adjusted FCF Growth Rate was 67.90% per year. During the past 3 years, the average Cyclically Adjusted FCF Growth Rate was 49.40% per year. During the past 5 years, the average Cyclically Adjusted FCF Growth Rate was 52.70% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of DexCom was 188.40% per year. The lowest was 23.10% per year. And the median was 49.40% per year.

As of today (2026-07-02), DexCom's current stock price is $68.86. DexCom's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2026 was $0.94. DexCom's Cyclically Adjusted Price-to-FCF of today is 73.26.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of DexCom was 7281.25. The lowest was 64.48. And the median was 445.00.


DexCom  (NAS:DXCM) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

DexCom's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=68.86/0.94
=73.26

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of DexCom was 7281.25. The lowest was 64.48. And the median was 445.00.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


DexCom Cyclically Adjusted FCF per Share Related Terms


DexCom Cyclically Adjusted FCF per Share Historical Data

* Premium members only.

The historical data trend for DexCom's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DexCom Cyclically Adjusted FCF per Share Chart

DexCom Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.14 0.24 0.37 0.53 0.80

DexCom Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.56 0.62 0.76 0.80 0.94

DXCM vs GEHC, STE, ZBH: Cyclically Adjusted FCF per Share Comparison

For the Medical Devices subindustry, DexCom's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DexCom Cyclically Adjusted Price-to-FCF vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, DexCom's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where DexCom's Cyclically Adjusted Price-to-FCF falls into.


DXCM
90GF Score
DexCom Inc DXCM
Cyclically Adjusted FCF per Share is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

DexCom Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, DexCom's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2026 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=1.141/330.2130*330.2130
=1.141

Current CPI (Mar. 2026) = 330.2130.

DexCom Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201606 0.029 241.018 0.040
201609 0.021 241.428 0.029
201612 -0.013 241.432 -0.018
201703 -0.066 243.801 -0.089
201706 0.007 244.955 0.009
201709 0.065 246.819 0.087
201712 0.068 246.524 0.091
201803 -0.069 249.554 -0.091
201806 0.087 251.989 0.114
201809 0.091 252.439 0.119
201812 0.045 251.233 0.059
201903 -0.076 254.202 -0.099
201906 0.048 256.143 0.062
201909 0.121 256.759 0.156
201912 0.269 256.974 0.346
202003 -0.083 258.115 -0.106
202006 0.247 257.797 0.316
202009 0.252 260.280 0.320
202012 0.281 260.474 0.356
202103 -0.172 264.877 -0.214
202106 -0.093 271.696 -0.113
202109 0.323 274.310 0.389
202112 0.059 278.802 0.070
202203 -0.071 287.504 -0.082
202206 0.193 296.311 0.215
202209 0.434 296.808 0.483
202212 0.162 296.797 0.180
202303 0.193 301.836 0.211
202306 0.304 305.109 0.329
202309 0.513 307.789 0.550
202312 0.194 306.746 0.209
202403 0.365 312.332 0.386
202406 0.512 314.175 0.538
202409 0.215 315.301 0.225
202412 0.435 315.605 0.455
202503 0.238 319.799 0.246
202506 0.512 322.561 0.524
202509 1.422 324.800 1.446
202512 0.482 324.054 0.491
202603 1.141 330.213 1.141

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

What does a Cyclically Adjusted FCF per Share of $0.94 mean?
DexCom (DXCM) has a Cyclically Adjusted FCF per Share of $0.94 as of Mar. 2026. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on DexCom and its competitors.
Is DexCom's Cyclically Adjusted FCF per Share too high?
DexCom's current Cyclically Adjusted FCF per Share is $0.94. Overall, DexCom has a GF Score™ of 90/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does DexCom's Cyclically Adjusted FCF per Share compare to GEHC and STE?
DexCom's Cyclically Adjusted FCF per Share of $0.94 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Cyclically Adjusted FCF per Share for a Medical Devices & Instruments company?
A good Cyclically Adjusted FCF per Share depends on the Medical Devices & Instruments industry context. However, Cyclically Adjusted FCF per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Cyclically Adjusted FCF per Share mean?
A high Cyclically Adjusted FCF per Share can signal that a stock is expensive relative to its fundamentals. Cyclically Adjusted FCF per Share represents the company's inflation-adjusted FCF per share over a 10-year period. View historical data on DexCom and its competitors. DexCom's current Cyclically Adjusted FCF per Share is $0.94. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DexCom stock overvalued right now?
Based on GuruFocus' analysis, DexCom (DXCM) is currently considered Significantly Undervalued. The stock's GF Value™ is $103.81, compared to a current price of $68.86 — trading 33.7% below its estimated fair value. The current Cyclically Adjusted FCF per Share is $0.94. DexCom's overall GF Score™ is 90/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Cyclically Adjusted FCF per Share calculated?
Cyclically Adjusted FCF per Share is calculated from a company's financial statements. For DexCom (DXCM), the current Cyclically Adjusted FCF per Share is $0.94 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is DexCom (DXCM) Overvalued in 2026?

Based on GuruFocus' analysis, DexCom stock appears to be undervalued. The current stock price of $68.86 is trading 33.7% below its estimated GF Value™ of $103.81. GuruFocus considers DexCom to be Significantly Undervalued.

Key valuation signals for DXCM:

  • Cyclically Adjusted FCF per Share: $0.94
  • GF Value™: $103.81 vs. price of $68.86 (33.7% below fair value)
  • GF Score™: 90/100 with 3 warning signs

No single metric tells the full story. See the DXCM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


DexCom Business Description

Address 6340 Sequence Drive, San Diego, CA, USA, 92121
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery. DexCom's CGMs are available through medical equipment distributors as well as retail pharmacies.
90GF Score

Get the complete analysis for DXCM

Cyclically Adjusted FCF per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$68.86
Price
$103.81
GF Value